J&J Profit Rises; Firm Boots Its Forecast
Johnson and Johnson’s revenue is increasing in the billions for the 3rd quarter. These strong sells are not due to medical devices or pharmaceutical but in consumer products instead. The revenue from consumer products rose 13%, mainly in Listerine, Neutrogena (Clean and Clear), and Aveeno skin care. Johnson and Johnson predict their earning to increase for the rest of the year.
Article found in: The Wall Street Journal
Article date: October 15, 2008
Subscribe to:
Post Comments (Atom)
1 comment:
Interesting--it's interesting to see some of the businesses that are posting profits for this quarter and the entire year.
Post a Comment